## INDUCTION: STANDARD RISK ALL 

This therapy is for all patients with NCI standard risk B-ALL

**VinCRIStine (VCR)**
-	Route: IV push over 1 minute
-	Dosage: 1.5 mg/m2/dose
-   Dilute with 10ml of 0.9% NaCl, IV infusion at 60ml/h
-	Used on Days 1, 8, 15, & 22
-	Caution: Maximum dose: 2 mg

**Dexamethasone (DEX)**
-	Route: PO (may give IV)
-	Dosage: 3 mg/m2/dose BID
-	Used on Days 1-28 (do not taper) (56 doses)
-	Caution: Total daily dose: 6 mg/m2/day, divided BID

**L-asparaginase**
-	Route: IM
-	Dosage: 6000 International Units/m2/dose (9 doses)
-	Used on Day 2, 4, 6 Day 8, 10, 12 Day 15, 17, 19
-	Caution: Monitor for one hour after dose for any signs/symptoms of allergic reaction/anaphylaxis

*Only CNS2 patients should receive IT MTX on day 15 and 22 

^End of induction bone marrow for pre-B-ALL only Pre-B-ALL patients with M2/M3 morphology on end of induction repeat bone marrow aspirate should be moved to the high-risk protocol (once able to safely be done)

